NSPR (InspireMD Corp) Market Value to Book Value Ratio

InspireMD, Inc. (NSPR) develops high-tech stents leveraging proprietary micro-mesh designs and an extensive base of clinical trials to validate safety. Its products are certified in the US and Europe, while surgeon trust creates a robust moat against new entrants. Stringent FDA oversight and cardiology lobbying solidify its leadership status, with a metric of 0.68. This chart illustrates the company's market valuation below.

This indicator determines the market value of assets relative to their book value. The calculation is based on dividing the current market capitalization by equity, identifying a premium or discount to net assets. By analyzing the price-to-book ratio, an investor assesses market optimism. For InspireMD, Inc. (NSPR), which utilizes outsourcing for production and logistics, this metric reflects the value of the brand and intellectual property over limited tangible resources.